Eric Marandett and Stephanie Schonewald on Inter Partes Review

View "Will the Pendulum Swing Back in IPR Proceedings?"

Eric Marandett and Stephanie Schonewald wrote “Will The Pendulum Swing Back In IPR Proceedings?” in Life Sciences Law360 where they discuss inter partes review being used by competitors in the pharmaceutical industry to knock out commercially significant patents.  They also debate whether or not balance will be restored in the IPR proceedings and discuss the new legislation introduced by Congress  to make significant modifications to IPR that would make it harder to invalidate patents.